Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Good Rx Appoints Christopher a. Mc Ginnis As Chief Financial Officer

PUBLIC · GDRXFeb 05, 2025•over 1 year ago

Position

Chief Financial Officer

Company

GoodRx

Christopher A. McGinnis

Santa MonicaSoftwareHealth CareMedical

Description

GoodRx (Nasdaq: GDRX) announced the appointment of Christopher A. McGinnis as Chief Financial Officer, effective February 4, 2025. With 30 years of extensive financial experience across the healthcare industry, Chris's appointment is expected to be an incredibly valuable asset for the company.

Company Information

Company

GoodRx

Location

Santa Monica, California, United States

About

GoodRx is the leading prescription savings platform in the U.S. Trusted by nearly 30 million consumers and over one million healthcare professionals annually, GoodRx provides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save over $75 billion on the cost of their prescriptions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for GoodRx's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months